Cargando…
Selective inhibition of stemness through EGFR/FOXA2/SOX9 axis reduces pancreatic cancer metastasis
Pancreatic cancer (PC) is difficult to defeat due to mechanism (s) driving metastasis and drug resistance. Cancer stemness is a major challenging phenomenon associated with PC metastasis and limiting therapy efficacy. In this study, we evaluated the pre-clinical and clinical significance of eradicat...
Autores principales: | Kaushik, Garima, Seshacharyulu, Parthasarathy, Rauth, Sanchita, Nallasamy, Palanisamy, Rachagani, Satyanarayana, Nimmakayala, Rama Krishna, Vengoji, Raghupathy, Mallya, Kavita, Chirravuri-Venkata, Ramakanth, Singh, Amar B, Foster, Jason M., Ly, Quan P., Smith, Lynette M., Lele, Subodh M., Malafa, Mokenge P., Jain, Maneesh, Ponnusamy, Moorthy P., Batra, Surinder K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7848971/ https://www.ncbi.nlm.nih.gov/pubmed/33288882 http://dx.doi.org/10.1038/s41388-020-01564-w |
Ejemplares similares
-
Reduction in O-glycome induces differentially glycosylated CD44 to promote stemness and metastasis in pancreatic cancer
por: Leon, Frank, et al.
Publicado: (2021) -
ST6GalNAc‐I promotes lung cancer metastasis by altering MUC5AC sialylation
por: Lakshmanan, Imayavaramban, et al.
Publicado: (2021) -
Afatinib and Temozolomide combination inhibits tumorigenesis by targeting EGFRvIII-cMet signaling in glioblastoma cells
por: Vengoji, Raghupathy, et al.
Publicado: (2019) -
Differential gene expression-based connectivity mapping identified novel drug candidate and improved Temozolomide efficacy for Glioblastoma
por: Vengoji, Raghupathy, et al.
Publicado: (2021) -
Elevated PAF1-RAD52 axis confers chemoresistance to human cancers
por: Rauth, Sanchita, et al.
Publicado: (2023)